User profiles for M Noursadeghi

Mahdad Noursadeghi

University College London
Verified email at ucl.ac.uk
Cited by 16153

Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection

LCK Bell, M Noursadeghi - Nature Reviews Microbiology, 2018 - nature.com
… This reflects recovery of innate immune inflammatory responses to M. tuberculosis, which
may be exacerbated by the recirculation of M. tuberculosis-reactive T cells and failure of the …

[HTML][HTML] Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis

…, M Lipman, I Abubakar, M Noursadeghi - The Lancet …, 2020 - thelancet.com
Background Multiple blood transcriptional signatures have been proposed for identification
of active and incipient tuberculosis. We aimed to compare the performance of systematically …

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, M Noursadeghi, M Olanipekun, A Osagie, M Palmarini… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

Towards host-directed therapies for tuberculosis

…, M Noursadeghi, P Elkington, M Bonnet… - Nature reviews Drug …, 2015 - nature.com
… For the past 60 years, efforts to develop new treatments have focused on compounds
and regimens that target M. tuberculosis directly. Recently, however, attention has focused …

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …

…, JS Nguyen-Van-Tam, L Norman, M Noursadeghi… - bmj, 2020 - bmj.com
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …

Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure

…, D Muñoz Sandoval, SM Murray, M Noursadeghi… - Science, 2022 - science.org
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …

[HTML][HTML] Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

…, L van Dorp, F Balloux, Á McKnight, M Noursadeghi… - Nature, 2022 - nature.com
Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
do not necessarily develop PCR or antibody positivity, suggesting that some …

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

…, T Cutino-Moguel, MK Maini, B Chain, M Noursadeghi… - Science, 2021 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided
with the spread of variants of concern. We investigated whether single-dose vaccination, …

[HTML][HTML] Evolution of enhanced innate immune evasion by SARS-CoV-2

…, N Jura, K Verba, M Noursadeghi, P Beltrao, M Kellis… - Nature, 2022 - nature.com
The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance
human-to-human transmission 1 , 2 . Although much effort has focused on the characterization …

[HTML][HTML] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

…, Á McKnight, DM Altmann, T Brooks, M Noursadeghi… - The Lancet, 2021 - thelancet.com
Most vaccine platforms use a two-dose prime-boost approach to generate an immune
response against the virus S1 spike protein, the titres of which correlate with functional virus …